“Polyol-Silk Bioink Formulations as Two-Part Room-Temperature Curable Materials for 3D Printing”
Advances in 3-D printing have led to new ways to make bone and some other relatively simple body parts that can be implanted in patients. But finding an ideal bio-ink has stalled progress toward printing more complex tissues with versatile functions — tissues that can be loaded with pharmaceuticals, for example. Now scientists, reporting in the journal ACS Biomaterials Science & Engineering, have developed a silk-based ink that could open up new possibilities toward that goal.
Most inks currently being developed for 3-D printing are made of thermoplastics, silicones, collagen and gelatin or alginate. But there are limits to how these inks can be used. For example, the temperatures, pH changes and crosslinking methods that may be required to toughen some of these materials can damage cells or other biological components that researchers would want to add to the inks. Additives, such as cytokines and antibiotics, are useful for directing stem cell functions and controlling infections, respectively. To address these bio-ink limitations, David L. Kaplan and colleagues turned to silk protein and developed a way to avoid these harsh processing conditions.
The researchers combined silk proteins, which are biocompatible, and glycerol, a non-toxic sugar alcohol commonly found in food and pharmaceutical products. The resulting ink was clear, flexible, stable in water, and didn’t require any processing methods, such as high temperatures, that would limit its versatility. The researchers say the novel material could potentially be used in biomedical implants and tissue engineering.
The Latest on: Bio-ink
via Google News
The Latest on: Bio-ink
- Leucid Bio, Lonza ink collaboration to leverage Cocoon Platform for automated manufacturing of personalised CAR T-cellson December 4, 2021 at 2:30 am
Leucid Bio, Lonza ink collaboration to leverage Cocoon Platform for automated manufacturing of personalised CAR T-cells: London Saturday, December 4, 2021, 16:00 Hrs [IST] Leucid ...
- SPARC, Biomodifying ink antibody licensing agreementon December 3, 2021 at 11:41 pm
Mumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) has recently announced that the company has entered into an agreement with Biomodifying LLC to exclusively license ...
- Scientists 3D-Print Programmable Living Structures With New Microbial Inkon November 29, 2021 at 10:09 am
The key to the breakthrough was to repurpose the proteins that E. coli cells secrete to stick together and form hard-to-shift biofilms.
- Sybil & Cyril by Jenny Uglow review: the unlikely artistic duo who shook up Britainon November 26, 2021 at 8:00 pm
Interwar Britain fizzes to life in an enchanting biography of two linocut artists – and their (allegedly) platonic obsession with each other ...
- Biography of a special caseon November 26, 2021 at 4:07 pm
Froshaug himself has always seemed a special case, someone to be spoken about in awed tones, even though few outside his circle could claim more than a glancing knowledge of his output. Kinross shows ...
- USDA makes air travel more sustainable with soy-fuel innovationson November 24, 2021 at 1:06 pm
Scientists with USDA Agricultural Research Service in Peoria, Illinois, have developed a way to make a better jet biofuel from soybean oil. Blends using biofuels are one of the ways the aviation ...
- Soy-fuel innovations for air travelon November 24, 2021 at 10:49 am
Scientists with the Agricultural Research Service (ARS) in Peoria, Illinois, have developed a way to make a better jet biofuel from soybean oil.
- 3D-printed 'living ink' is full of microbes and can release drugson November 23, 2021 at 8:36 am
A living ink made entirely from bacterial cells can be 3D-printed to make structures that release anti-cancer drugs or mop up toxins from the environment ...
- Scientists crack aromatic conumdrum in developing SAF from soybean oilon November 23, 2021 at 6:58 am
Scientists have developed a way to make a better sustainable aviation fuel from soybean oil. The team from the Agricultural Research Service (ARS) in Peoria, ...
- Sosei, Neurocrine ink $2.6B neuropsychiatric collaborationon November 22, 2021 at 9:41 am
LONDON – Sosei Heptares is to get $100 million up front in a potential $2.6 billion deal with Neurocrine Biosciences Inc., in which the pair will develop muscarinic receptor agonists in the treatment ...
via Bing News